Ethical Republicans and others who have supported the president must not embrace Attorney General William Barr’s summary as proof that Trump is in the clear.
It is easy to take vaccines for granted since their very success, the elimination of diseases, makes their value invisible. It’s hard to appreciate what one does not experience.
Without any evidence anywhere in the text of the proposal, detractors insist the deal would ban cars, airplanes and even cows. Those are trumped-up, imaginary fears.
The art and nature campus is launching an array of projects to upgrade its offerings and public access, highlighted by an autumnal festival this fall including culinary attractions, horticulture displays, musical performances and films.
The Indianapolis-based drugmaker could spend more than a half-billion dollars under a licensing deal with ImmuNext of New Hampshire to identify and commercialize a new antibody for immune diseases.
Officials for the Indianapolis-based transmission giant tell city officials that the project would create 193 jobs that pay an average of $20.39 per hour, as well as help it retain current employees.
Local companies—be they big corporations or small startups—need a strong talent pool from which to draw their workers. State and local governments need a healthy tax base from which to pull revenue to keep the region’s infrastructure—roads, mass transit, internet access and more—strong enough for business. And the region needs residents who invest time, money and energy into their homes, their schools and their community at large. None of that can happen when a large percentage of the population is economically drowning.
More than 20 years after founding his tech consulting and development firm Studio Science, Kristian Andersen has sold the company to a group of investors led by CEO Steve Pruden.
Some of the most prominent hotel operators in downtown Indianapolis told state lawmakers Wednesday that the process that led to developer Kite Realty Group Trust and Hilton being selected for the Pan Am Plaza project was unfair.
U.S. regulators on Friday gave the green light to salmon genetically modified to grow about twice as fast as normal, but the company behind it may face legal challenges before the fish can be sold domestically.
